News

This has been an unnerving year for investors. COVID-19 went from a minor news story in China to a full-blown global pandemic. Government lockdowns took effect, business activity ground to a halt

Nike (NYSE: NKE) surprised investors in late March by revealing strong operating trends in China despite challenging financial headwinds brought on by store closures from the COVID-19 pandemic. The

E-commerce in Latin America is still in its early innings, with online purchases accounting for just 4% of total retail sales in 2019. By contrast, digital purchases represented about 11% of total

Americans need more COVID-19 money, but it's not clear whether an additional direct payment will come. One of the problems that's making it challenging for lawmakers to authorize more coronavirus

Crude oil prices screamed higher last month. WTI, the leading U.S. oil price benchmark, zoomed 88%, pushing back over $35 a barrel. That big-time bounce back gave several oil producers the

Costco's (NASDAQ: COST) business and traffic will likely improve as the economy reopens. The company is well positioned as a safe option for people still concerned about COVID-19. Costco is also

When you think of cannabis stocks, the idea of receiving dividends probably doesn't come to mind. After all, many cannabis companies aren't generating profits yet. Paying dividends isn't even on

Spotify (NYSE: SPOT) is expanding its push into original podcasts again with an exclusive deal with Warner Bros. and DC Comics. The multi-year deal with the AT&T subsidiary gives Spotify the ability

Since the coronavirus pandemic struck the economy, both Bank of America (NYSE: BAC) and Citigroup (NYSE: C), two of the largest banks in the world, have been hit hard. Bank of America's share price

Buying shares of a company that's in a transition can sometimes pay off nicely. Such transitions can lead to a resurgence in growth that fuels a major stock jump.

Biogen (NASDAQ: BIIB) and Bristol

Retirement can be a daunting prospect on many levels, and it's natural to have concerns about it, especially as that milestone approaches. The good news, however, is that there are steps you can

The coronavirus pandemic has sent the U.S. economy into a deep recession, which began in February. In March, a broad market plunge sent many stocks into free fall, but the markets have since

Last week was another good one for healthcare stocks across the board, and a stellar week for investors holding shares of these recent high flyers. 

Now that they've made some big gains, investors

Throughout America, many states are slowly reopening their economies after the Great Lockdown necessary to slow the spread of COVID-19. But for some families, the financial damage done by the

After many long years as a clinical-stage biotech, successful new drugs are beginning to pour out of Alnylam (NASDAQ: ALNY). The FDA's currently reviewing the third new drug application from the

Finding a good dividend stock can be challenging since there's so much uncertainty relating to the COVID-19 pandemic. However, investors simply need to adapt and look for safer options right now to

With the stock market nearly all the way back to where it started the year, some may think the rally of the last few months may be running out of steam. While I'm not sure that's the case -- it's

Gilead Sciences (NASDAQ: GILD) is among many biotech and pharmaceutical companies working on treatments for COVID-19, the illness caused by the novel coronavirus. Where Gilead stands apart is it

More than 20 million Americans are out of work and receiving unemployment benefits, largely due to the COVID-19 pandemic. And yet, you wouldn't know that there's a problem in the economy from

Social Security is in trouble. In April, the program's Trustees reported that Social Security's trust funds could run out of money by 2035. Once that happens, the program may have no choice but to

Health savings accounts (HSAs) are one of the most valuable tax-advantaged investments, but they're often overlooked.

HSAs aren't open to everyone; you need a qualifying high-deductible health plan

For the last three years, Gilead Sciences (NASDAQ: GILD) hasn't done much more than treading water. Sure, the stock is up during the period, but all of the gains came in 2020 with COVID-19 drug

If the coronavirus disease 2019 (COVID-19) pandemic has taught investors anything, it's that staying the course on great companies, no matter how dire things may seem, is almost always a prudent

Millions of Americans have lost their jobs in the wake of COVID-19, and earlier this month, economists declared that we have a full-blown recession on our hands. Thankfully, there's been relief for

Teladoc Health (NYSE: TDOC) is the leader of telemedicine in the U.S. With its massive network of board-certified clinicians, Teladoc aims to supply health insurance companies and large employers